Skip to main content
An official website of the United States government
Email

Global Launch of Women, Power, and Cancer: A Lancet Commission

September 27, 2023 | 8:00 AM – 10:30 AM

Geneva Graduate Institute Pictet Auditorium Geneva, Switzerland

Add to Outlook Calendar

Register Now to Join Virtually

8:00a.m. - 10:30a.m. ET
2:00p.m. - 4:30p.m. CET

The  Lancet Commission on women, power, and cancer was created to investigate the nexus of women, power, and cancer. As such, it's collective work looks beyond “women’s cancers” and the biomedical aspects of any type of cancer that women- in all their diversities - might experience. It is inclusive of the ways in which sex and gender influence exposures to cancer risk factors, interactions with the cancer health system, and specific challenges faced by healthcare professionals, advocates, and caregivers. In all these domains, women can experience gender bias and overlapping forms of discrimination, such as those due to age, race, ethnicity, socio-economic status, sexual orientation, and gender identity, that render them structurally marginalized. 

By applying an intersectional feminist approach, the Commission investigates, exposes, and challenges the prevailing asymmetries of power in relation to cancer in three key domains: decision-making, knowledge, and economics.

This launch event will present key findings and propose a set of recommendations to inspire real-world action for transformational change. The event will feature Commission speakers in a discussion of key findings and recommendations of the report and a moderated panel discussion with thought leaders in global health and development, cancer policy, and women’s rights. Panels will be moderated by Dr. Vania Wisdom, Executive Editor and Oncology Ambassador at The Lancet, and Dr. Richard Horton, Editor-in-Chief at The Lancet. Visit the Commission website to learn more about the Commission goals.

Visit the Commission website to learn more about the Lancet Commission on Women, power, and cancer.

The Commission global launch is presented by The Lancet, the U.S. National Cancer Institute, GENDRO, and The Geneva Graduate Institute. 

Email